Linical is a global Contract Research Organization (CRO) for full-service drug development, with a proven record of helping biopharmaceutical companies successfully navigate the clinical development journey. Linical supports clients ranging from small, virtual biotechs to large, top 10 pharma companies, with a global presence across all major markets including Asia-Pacific (APAC), North America, and Europe. Linical provides a full spectrum of drug development services from early stage to large-scale, multinational studies. Combining strong business perspective with clinical and medical expertise, Linical goes beyond operational excellence, providing flexibility, guidance, and key strategies to successfully overcome drug development and regulatory challenges. They strive to offer professional, high-quality services with the personal attention needed in a constantly evolving pharmaceutical and biotech market. Linical’s areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases.